Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE GUERLESQUIN : revenue, balance sheet and financial ratios

PHARMACIE DE GUERLESQUIN is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in GUERLESQUIN (29650), this company of category PME shows in 2025 a net income positive of 178 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE GUERLESQUIN (SIREN 824494223)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 177 557 € 153 781 € 165 147 € 184 973 € 185 386 € 167 221 € 168 306 € 75 480 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE DE GUERLESQUIN generates positive net income of 178 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 75 k€ -> 178 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

177 557 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 40%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

39.844%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

64.112%

Solvency indicators evolution
PHARMACIE DE GUERLESQUIN

Sector positioning

Debt ratio
39.84 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good -11 pts over 3 years

In 2025, the debt ratio of PHARMACIE DE GUERLESQUIN (39.84) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
64.11% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +13 pts over 3 years

In 2025, the financial autonomy of PHARMACIE DE GUERLESQUIN (64.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Positioning of PHARMACIE DE GUERLESQUIN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DE GUERLESQUIN is estimated at 2 820 514 € (range 1 914 014€ - 4 425 774€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1914k€ 2820k€ 4425k€
2 820 514 € Range: 1 914 014€ - 4 425 774€
NAF 5 année 2025

Valuation method used

Net Income Multiple
177 557 € × 15.9x = 2 820 514 €
Range: 1 914 014€ - 4 425 775€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE GUERLESQUIN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE GUERLESQUIN

What is the revenue of PHARMACIE DE GUERLESQUIN ?

The revenue of PHARMACIE DE GUERLESQUIN is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE GUERLESQUIN profitable?

Yes, PHARMACIE DE GUERLESQUIN generated a net profit of 178 k€ in 2025.

Where is the headquarters of PHARMACIE DE GUERLESQUIN ?

The headquarters of PHARMACIE DE GUERLESQUIN is located in GUERLESQUIN (29650), in the department Finistere.

Where to find the tax return of PHARMACIE DE GUERLESQUIN ?

The tax return of PHARMACIE DE GUERLESQUIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE GUERLESQUIN operate?

PHARMACIE DE GUERLESQUIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.